The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a Difference.


In this article, the four coordinators of neglected tropical disease (NTD) drug development projects funded under the European Commission (EC) Framework Programme 7 argue that the EC should reassess their funding strategy to cover the steps necessary to translate a lead compound into a drug candidate for testing in clinical trials, and suggest ways in which this might be achieved.


PubMed ID: 28529130

Projects: NMTrypI - New Medicines for Trypanosomatidic Infections

Publication type: Journal

Journal: Trends Parasitol

Citation: Trends Parasitol. 2017 Aug;33(8):581-583. doi: 10.1016/ Epub 2017 May 18.

Date Published: 23rd May 2017

Registered Mode: by PubMed ID

Authors: R. J. Pierce, J. MacDougall, R. Leurs, M. P. Costi

help Submitter

Views: 497

Created: 22nd Jul 2020 at 17:19

help Tags

This item has not yet been tagged.

help Attributions


Powered by
Copyright © 2008 - 2022 The University of Manchester and HITS gGmbH

By continuing to use this site you agree to the use of cookies